{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:10:59Z","timestamp":1792591859144,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.numecd.2024.103792","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T16:20:27Z","timestamp":1731774027000},"page":"103792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Two still unanswered questions about uric acid and cardiovascular prevention: Is a specific uric acid cut-off needed? Is hypouricemic treatment able to reduce cardiovascular risk?"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2612-6264","authenticated-orcid":false,"given":"Alessandro","family":"Maloberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4088-463X","authenticated-orcid":false,"given":"Francesca","family":"Daus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"De Censi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0237-7157","authenticated-orcid":false,"given":"Maurizio Giuseppe","family":"Abrignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6220-2471","authenticated-orcid":false,"given":"Pier Luigi","family":"Temporelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Binaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furio","family":"Colivicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2024.103792_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000355405","article-title":"Uric acid \u2014 key ingredient in the recipe for cardiorenal metabolic syndrome","volume":"3","author":"Chaudhary","year":"2013","journal-title":"Cardiorenal Med"},{"issue":"5","key":"10.1016\/j.numecd.2024.103792_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40292-023-00602-4","article-title":"The results of the URRAH (uric acid right for heart health) project: a focus on hyperuricemia in relation to cardiovascular and kidney disease and its role in metabolic dysregulation","volume":"30","author":"Maloberti","year":"2023","journal-title":"High Blood Pres Cardiovasc Prev"},{"key":"10.1016\/j.numecd.2024.103792_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jch.14613","article-title":"Uric acid relationships with lipid profile and adiposity indices: impact of different hyperuricemic thresholds","volume":"25","author":"Maloberti","year":"2023","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.numecd.2024.103792_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cca.2018.05.046","article-title":"Uric acid and cardiovascular disease","volume":"484","author":"Ndrepepa","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.numecd.2024.103792_bib5","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.3390\/jcm10204750","article-title":"The role of uric acid in acute and chronic coronary syndromes","volume":"10","author":"Maloberti","year":"2021","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.numecd.2024.103792_bib6","first-page":"1503","article-title":"Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study","volume":"37","author":"Bos","year":"2006"},{"key":"10.1016\/j.numecd.2024.103792_bib7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5551\/jat.39917","article-title":"Effect of thyroxin treatment on carotid IntimaMedia thickness (CIMT) reduction in patients with subclinical hypothyroidism (SCH): a meta-analysis of clinical trials","volume":"24","author":"Aziz","year":"2017","journal-title":"J Atherosclerosis Thromb"},{"key":"10.1016\/j.numecd.2024.103792_bib8","first-page":"25","article-title":"Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis. Congest","volume":"17","author":"Tamariz","year":"2011","journal-title":"Heart Fail"},{"issue":"7","key":"10.1016\/j.numecd.2024.103792_bib9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.numecd.2023.05.002","article-title":"Uric acid significantly correlates with the presence of low-voltage areas at the endocardial mapping in patients with non-valvular atrial fibrillation","volume":"33","author":"Baroni","year":"2023","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"12","key":"10.1016\/j.numecd.2024.103792_bib10","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"ESH Guidelines for the management of arterial hypertension","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2024.103792_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejim.2020.07.013","article-title":"Impact of admission serum acid uric levels on in-hospital outcomes in patients with acute coronary syndrome","volume":"82","author":"Centola","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.numecd.2024.103792_bib12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.amjcard.2011.09.042","article-title":"Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention","volume":"109","author":"Kaya","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2024.103792_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000496053","article-title":"Impact of accumulated serum uric acid on coronary culprit lesion morphology determined by optical coherence tomography and cardiac outcomes in patients with acute coronary syndrome","volume":"141","author":"Kobayashi","year":"2018","journal-title":"Cardiology"},{"key":"10.1016\/j.numecd.2024.103792_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11739-011-0515-9","article-title":"Uric acid in the early risk stratification of ST-elevation myocardial infarction","volume":"7","author":"Lazzeri","year":"2012","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.numecd.2024.103792_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1236837","article-title":"Serum uric acid as an independent risk factor for the presence and severity of early-onset coronary artery disease: a case-control study","author":"Tian","year":"2018","journal-title":"Dis Markers"},{"key":"10.1016\/j.numecd.2024.103792_bib16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/0003319711426868","article-title":"High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome","volume":"63","author":"Duran","year":"2012","journal-title":"Angiology"},{"key":"10.1016\/j.numecd.2024.103792_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10554-018-1446-6","article-title":"Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and\/or unprotected left main disease","volume":"35","author":"Karabag","year":"2019","journal-title":"Int J Cardiovasc Imag"},{"key":"10.1016\/j.numecd.2024.103792_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11302-018-9604-9","article-title":"Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome","volume":"14","author":"Gaubert","year":"2018","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.numecd.2024.103792_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.atherosclerosis.2015.03.030","article-title":"Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: a single-centre study","volume":"241","author":"Barbieri","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2024.103792_bib20","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.numecd.2021.01.023","article-title":"Uric acid in chronic coronary syndromes: relationship with coronary artery disease severity and left ventricular diastolic parameter","author":"Maloberti","year":"2021","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2024.103792_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.785327","article-title":"Serum uric acid and risk of chronic heart failure: a systematic review and meta-analysis","volume":"8","author":"Miao","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.numecd.2024.103792_bib22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41598-018-37053-0","article-title":"High serum uric acid is highly associated with a reduced left ventricular ejection fraction rather than increased plasma B-type natriuretic peptide in patients with cardiovascular diseases","volume":"9","author":"Oki","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2024.103792_bib23","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1253\/circj.70.1006","article-title":"Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure","volume":"70","author":"Sakai","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.numecd.2024.103792_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3724\/SP.J.1263.2011.11281","article-title":"Serum uric acid as an index of impaired renal function in congestive heart failure","volume":"9","author":"Tian","year":"2012","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.numecd.2024.103792_bib25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/HYPERTENSIONAHA.110.161505","article-title":"Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis","volume":"57","author":"Dorsch","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2024.103792_bib26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ehf2.12390","article-title":"Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care","volume":"6","author":"Okazaki","year":"2019","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.numecd.2024.103792_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/HJH.0000000000002589","article-title":"Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study","volume":"39","author":"Muiesan","year":"2021","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.numecd.2024.103792_bib28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11926-013-0400-9","article-title":"The crystallization of monosodium urate","volume":"16","author":"Martillo","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.numecd.2024.103792_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/HYPERTENSIONAHA.116.08436","article-title":"Uric acid is associated with inflammation, coronary microvascular dysfunction, and adverse outcomes in postmenopausal women","volume":"69","author":"Prasad","year":"2017","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.numecd.2024.103792_bib30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000496053","article-title":"Impact of accumulated serum uric acid on coronary culprit lesion morphology determined by optical coherence tomography and cardiac outcomes in patients with acute coronary syndrome","volume":"141","author":"Kobayashi","year":"2018","journal-title":"Cardiology"},{"key":"10.1016\/j.numecd.2024.103792_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.atherosclerosis.2018.02.014","article-title":"Elevated serum uric acid predicts the development of moderate coronary artery calcification independent of conventional cardiovascular risk factors","volume":"272","author":"Jun","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2024.103792_bib32","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/HJH.0000000000000161","article-title":"Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality","volume":"32","author":"Bombelli","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2024.103792_bib33","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/00004872-200107000-00005","article-title":"Serumuric acid and the risk for hypertension and type 2 diabetes in Japanesemen: the Osaka Health Survey","volume":"19","author":"Taniguchi","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2024.103792_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00392-021-01815-0","article-title":"The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk","volume":"110","author":"Pugliese","year":"2021","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"10.1016\/j.numecd.2024.103792_bib35","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/HYPERTENSIONAHA.122.17956","article-title":"Uric acid and hypertension: a review of evidence and future perspectives for management of cardiovascular risk","volume":"79","author":"Borghi","year":"2022","journal-title":"Hyertension"},{"key":"10.1016\/j.numecd.2024.103792_bib36","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.amjcard.2005.07.068","article-title":"Status of endothelial dependent vasodilation in patients with hyperuricemia","volume":"96","author":"Kato","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2024.103792_bib37","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1523-1755.2004.00909.x","article-title":"Uric acid and the state of the intrarenal renin-angiotensin system in humans","volume":"66","author":"Perlstein","year":"2004","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.numecd.2024.103792_bib38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta-analysis","volume":"63","author":"Grayson","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"12","key":"10.1016\/j.numecd.2024.103792_bib39","first-page":"148","article-title":"A study on serum uric acid levels in type 2 diabetes mellitus and its association with cardiovascular risk factors","volume":"3","author":"Rao","year":"2016","journal-title":"IAIM"},{"issue":"1","key":"10.1016\/j.numecd.2024.103792_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40620-021-00985-4","article-title":"Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project","volume":"35","author":"Russo","year":"2022","journal-title":"J Nephrol"},{"key":"10.1016\/j.numecd.2024.103792_bib41","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","article-title":"A role for uric acid in the progression of renal disease","volume":"13","author":"Kang","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2024.103792_bib42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.jrn.2010.10.024","article-title":"Serum uric acid as a new player in the development of diabetic nephropathy","volume":"21","author":"Hovind","year":"2011","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.numecd.2024.103792_bib43","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2215\/CJN.13121215","article-title":"CRIC Study Investigators. Inflammation and progression of CKD: the CRIC study","volume":"11","author":"Amdur","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2024.103792_bib44","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.ki.5000212","article-title":"The relationship between albuminuria, MCP-1\/CCL2, and interstitial macrophages in chronic kidney disease","volume":"69","author":"Eardley","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2024.103792_bib45","first-page":"220","volume":"vol. 29","author":"Rebora","year":"2020"},{"key":"10.1016\/j.numecd.2024.103792_bib46","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1399-0012.2010.01244.x","article-title":"Serum uric acid level is associated with cardiac hypertrophy in renal transplant recipients","volume":"25","author":"Caliskan","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.numecd.2024.103792_bib47","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/01.HYP.0000161184.10873.ea","article-title":"Serum uric acid and target organ damage in primary hypertension","volume":"45","author":"Viazzi","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2024.103792_bib48","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/eci.12331","article-title":"Uricaemia and left ventricular mass in hypertensive patients","volume":"44","author":"Catena","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.numecd.2024.103792_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejim.2023.04.010","article-title":"Serum uric acid and left ventricular mass index independently predict cardiovascular mortality: the uric acid right for heart health (URRAH) project","volume":"114","author":"Muiesan","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.numecd.2024.103792_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2021.101723","article-title":"Role of diet in hyperuricemia and gout","volume":"35","author":"Danve","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.numecd.2024.103792_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13075-021-02444-8","article-title":"The comparative effect of exposure to various risk factors on the risk of hyperuricaemia: diet has a weak causal effect","volume":"23","author":"Topless","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.numecd.2024.103792_bib52","article-title":"Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts","volume":"363","author":"Major","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.numecd.2024.103792_bib53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/art.41067","article-title":"Population impact attributable to modifiable risk factors for hyperuricemia","volume":"72","author":"Choi","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.numecd.2024.103792_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/art.1780260115","article-title":"Trends in serum uric acid levels 1961--1980","volume":"26","author":"Glynn","year":"1983","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.numecd.2024.103792_bib55","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/obr.12940","article-title":"Impact of bariatric surgery on serum uric acid levels and the incidence of gout-A meta-analysis","volume":"20","author":"Yeo","year":"2019","journal-title":"Obes Rev"},{"issue":"5","key":"10.1016\/j.numecd.2024.103792_bib56","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1159\/000509934","article-title":"Prevention and treatment of tumor lysis syndrome in the era of onco-nephrology progress","volume":"45","author":"Matuszkiewicz-Rowinska","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.numecd.2024.103792_bib57","series-title":"Harrison's Principles of internal medicine","first-page":"2158","article-title":"Gout and other disorders of purine metabolism","author":"Wortman","year":"1998"},{"issue":"6","key":"10.1016\/j.numecd.2024.103792_bib58","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.ackd.2012.07.009","article-title":"Renal transport of uric acid: evolving concepts and uncertainties","volume":"19","author":"Bobulescu","year":"2012","journal-title":"Adv Chron Kidney Dis"},{"key":"10.1016\/j.numecd.2024.103792_bib59","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1086\/302936","article-title":"Juvenile hyperuricemic nephropathy: localization of the gene on chromosome 16p11.2\u2014and evidence for genetic heterogeneity","volume":"66","author":"Stiburkova","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.numecd.2024.103792_bib60","first-page":"1295","article-title":"Is it time to revise the normal range of serum uric acid levels?","volume":"18","author":"Desideri","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"10.1016\/j.numecd.2024.103792_bib61","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/HJH.0000000000000701","article-title":"Serum uric acid and the risk of cardiovascular and renal disease","volume":"33","author":"Borghi","year":"2015","journal-title":"J Hypertens"},{"issue":"14","key":"10.1016\/j.numecd.2024.103792_bib62","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.164.14.1546","article-title":"Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study","volume":"164","author":"Niskanen","year":"2004","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.numecd.2024.103792_bib63","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/nep.13559","article-title":"Hyperuricemia is associated with acute kidney injury and all-cause mortality in hospitalized patients","volume":"24","author":"Kang","year":"2019","journal-title":"Nephrology"},{"issue":"3","key":"10.1016\/j.numecd.2024.103792_bib64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/00365513.2019.1576098","article-title":"Long-term prognostic impact of hyperuricemia in community","volume":"79","author":"Kerola","year":"2019","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"10.1016\/j.numecd.2024.103792_bib65","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12933-023-02006-z","article-title":"Sex-related differences for uric acid in the prediction of cardiovascular events in essential hypertension. A population prospective study","volume":"22","author":"Perticone","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.numecd.2024.103792_bib66","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.STR.29.3.635","article-title":"Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus","volume":"29","author":"Lehto","year":"1998","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.numecd.2024.103792_bib67","article-title":"Asymptomatic hyperuricemia as an independent risk factor for myocardial infarction in adult population: a four-year follow-up study","volume":"15","author":"Talpur","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.numecd.2024.103792_bib68","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.119.13643","article-title":"Identification of the uric acid thresholds predicting an increased total and cardiovascular mortality over 20 years","volume":"75","author":"Virdis","year":"2020","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.numecd.2024.103792_bib69","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/metabo13020244","article-title":"Serum uric acid predicts all-cause and cardiovascular mortality independently of hypertriglyceridemia in cardiometabolic patients without established CV disease: a sub-analysis of the URic acid right for heArt health (URRAH) study","volume":"13","author":"Mengozzi","year":"2023","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.numecd.2024.103792_bib70","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.numecd.2022.01.028","article-title":"From the Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension. Serum uric acid levels threshold for mortality in diabetic individuals: the URic acid Right for heArt Health (URRAH) project","volume":"32","author":"Masulli","year":"2022","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.numecd.2024.103792_bib71","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41371-021-00613-5","article-title":"Working group on uric acid and cardiovascular risk of the Italian society of hypertension (SIIA). Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the uric acid right for heart health (URRAH) study","volume":"36","author":"Tikhonoff","year":"2022","journal-title":"J Hum Hypertens"},{"issue":"3","key":"10.1016\/j.numecd.2024.103792_bib72","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/HJH.0000000000002287","article-title":"Working group on uric acid and cardiovascular risk of the Italian society of hypertension (SIIA). Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: the URRAH (uric acid right for heart health) study","volume":"38","author":"Casiglia","year":"2020","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.numecd.2024.103792_bib73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1515\/cclm-2015-0523","article-title":"Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis","volume":"54","author":"Braga","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"10.1016\/j.numecd.2024.103792_bib74","first-page":"119","article-title":"Predictive value of elevated uric acid in Turkish patients undergoing primary angioplasty for ST elevation myocardial infarction","volume":"30","author":"Akgul","year":"2014","journal-title":"Acta Cardiol Sin"},{"issue":"1","key":"10.1016\/j.numecd.2024.103792_bib75","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.atherosclerosis.2011.07.021","article-title":"The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI","volume":"219","author":"Akpek","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2024.103792_bib76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejim.2020.10.001","article-title":"Serum uric acid and mortality thresholds among men and women in the Irish health system: a cohort study","volume":"84","author":"Browne","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.numecd.2024.103792_bib77","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007523","article-title":"U-shaped association between serum uric acid levels with cardiovascular and all-cause mortality in the elderly: the role of malnourishment","volume":"7","author":"Tseng","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.numecd.2024.103792_bib78","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.40472","article-title":"U-shaped association between serum uric acid level and risk of mortality: a cohort study","volume":"70","author":"Cho","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.numecd.2024.103792_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107206","article-title":"Association of serum uric acid with risk of stroke in US adults: a cross-sectional study from NHANES 1999-2020","volume":"32","author":"Gao","year":"2023","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"10.1016\/j.numecd.2024.103792_bib80","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/HJH.0000000000003068","article-title":"The association of uric acid with mortality modifies at old age: data from the uric acid right for heart health (URRAH) study","volume":"40","author":"Ungar","year":"2022","journal-title":"J Hypertens"},{"issue":"1132","key":"10.1016\/j.numecd.2024.103792_bib81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/postgradmedj-2019-136650","article-title":"J-shaped association between serum uric acid and acute coronary syndrome in patients with essential hypertension","volume":"96","author":"Shen","year":"2020","journal-title":"Postgrad Med"},{"issue":"7","key":"10.1016\/j.numecd.2024.103792_bib82","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/qjmed\/hct083","article-title":"Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality","volume":"106","author":"Stack","year":"2013","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.numecd.2024.103792_bib83","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C","article-title":"The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients","volume":"43","author":"Caspi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.numecd.2024.103792_bib84","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.2147\/IJGM.S320378","article-title":"Association between low-dose aspirin and uric acid in the elderly: an observational retrospective cross-sectional study","volume":"14","author":"Li","year":"2021","journal-title":"Int J Gen Med"},{"issue":"5","key":"10.1016\/j.numecd.2024.103792_bib85","first-page":"2719","article-title":"Effect of low-dose aspirin on serum uric acid levels in Chinese individuals over 60: subanalysis of a multicentre randomized clinical trial","volume":"24","author":"Zhang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.numecd.2024.103792_bib86","article-title":"Exploring the association between low-dose aspirin intake and hyperuricemia in individuals over 40: a cross-sectional study using NHANES data (2011-2018)","volume":"29","author":"Zhu","year":"2023","journal-title":"Med Sci Mon Int Med J Exp Clin Res"},{"issue":"5","key":"10.1016\/j.numecd.2024.103792_bib87","first-page":"679","article-title":"Drug-induced hyperuricaemia and gout","volume":"56","author":"Ben Salem","year":"2017","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.numecd.2024.103792_bib88","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1751-7176.2011.00512.x","article-title":"Thiazide and loop diuretics","volume":"1","author":"Sica","year":"2011","journal-title":"J Clin Hypertension (Greenwich)"},{"issue":"5\u20136","key":"10.1016\/j.numecd.2024.103792_bib89","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1023\/B:CARD.0000015855.02485.e3","article-title":"Cardiovascular drugs and serum uric acid","volume":"17","author":"Reyes","year":"2003","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"10.1016\/j.numecd.2024.103792_bib90","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/HJH.0000000000002600","article-title":"Cardiovascular Risk of the Italian Society of Hypertension (SIIA). Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study","volume":"39","author":"Maloberti","year":"2021","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.numecd.2024.103792_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/acr.24180","article-title":"American college of rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.numecd.2024.103792_bib92","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/BOR.0000000000000779","article-title":"The role of diet in hyperuricemia and gout HHS public access","volume":"33","author":"Yokose","year":"2021","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.numecd.2024.103792_bib93","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-198611050-00001","article-title":"Clinical pharmacokinetics of allopurinol","volume":"11","author":"Murrell","year":"1986","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"10.1016\/j.numecd.2024.103792_bib94","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1468-3083.2011.04313.x","article-title":"Cutaneous adverse drug reactions to allopurinol: 10 year observational survey of the dermatology department - cagliari University (Italy)","volume":"26","author":"Atzori","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.numecd.2024.103792_bib95","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B\u22175801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.numecd.2024.103792_bib96","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.clinthera.2009.11.033","article-title":"Febuxostat: a selective xanthine-oxidase\/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout","volume":"31","author":"Ernst","year":"2009","journal-title":"Clin Therapeut"},{"issue":"11","key":"10.1016\/j.numecd.2024.103792_bib97","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial","volume":"59","author":"Schumacher","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"23","key":"10.1016\/j.numecd.2024.103792_bib98","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.numecd.2024.103792_bib99","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar2978","article-title":"The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial","volume":"12","author":"Becker","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"13","key":"10.1016\/j.numecd.2024.103792_bib100","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.12998\/wjcc.v7.i13.1717","article-title":"Liver failure associated with benzbromarone: a case report and review of the literature","volume":"7","author":"Zhang","year":"2019","journal-title":"World J Clin Cases"},{"issue":"4","key":"10.1016\/j.numecd.2024.103792_bib101","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/ard.33.4.391","article-title":"Pharmacology of uricosuric drugs","volume":"33","author":"Kippen","year":"1974","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.numecd.2024.103792_bib102","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10067-021-05930-1","article-title":"A historical journey of searching for uricosuric drugs","volume":"41","author":"Jansen","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.numecd.2024.103792_bib103","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10067-006-0528-3","article-title":"Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients","volume":"26","author":"Reinders","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.numecd.2024.103792_bib104","doi-asserted-by":"crossref","DOI":"10.1186\/s41927-023-00335-w","article-title":"What are the core recommendations for gout management in first line and specialist care? Systematic review of clinical practice guidelines","volume":"7","author":"Conley","year":"2023","journal-title":"BMC Rheumatol."},{"issue":"7","key":"10.1016\/j.numecd.2024.103792_bib105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/bdd.1909","article-title":"SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria","volume":"35","author":"Chino","year":"2014","journal-title":"Biopharm Drug Dispos"},{"issue":"5","key":"10.1016\/j.numecd.2024.103792_bib106","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2215\/CJN.11480821","article-title":"SGLT2 inhibition and uric acid excretion in patients with type 2 diabetes and normal kidney function","volume":"17","author":"Suijk","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.numecd.2024.103792_bib107","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/jamacardio.2022.5608","article-title":"Association of dapagliflozin use with clinical outcomes and the introduction of uric acid-lowering therapy and colchicine in patients with heart failure with and without gout: a patient-level pooled meta-analysis of DAPA-HF and deliver","volume":"8","author":"Butt","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"9","key":"10.1016\/j.numecd.2024.103792_bib108","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1111\/dom.15157","article-title":"Serum uric acid lowering and effects of sodium-glucose cotransporter-2 inhibitors on gout: a meta-analysis and meta-regression of randomized controlled trials","volume":"25","author":"Banerjee","year":"2023","journal-title":"Diabetes Obes Metabol"},{"issue":"7","key":"10.1016\/j.numecd.2024.103792_bib109","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1169","article-title":"Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment","volume":"306","author":"Sundy","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.numecd.2024.103792_bib110","doi-asserted-by":"crossref","DOI":"10.1097\/NAN.0000000000000510","article-title":"Pegloticase in uncontrolled gout: the infusion nurse perspective","volume":"46","author":"Baxter","year":"2023","journal-title":"J Infusion Nurs"},{"issue":"13","key":"10.1016\/j.numecd.2024.103792_bib111","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.numecd.2024.103792_bib112","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1080\/14656566.2018.1532503","article-title":"The future of febuxostat after the cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular morbidities (CARES) trial: who CARES?","volume":"19","author":"Katsiki","year":"2018","journal-title":"Expet Opin Pharmacother"},{"issue":"10264","key":"10.1016\/j.numecd.2024.103792_bib113","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(20)32234-0","article-title":"Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial","volume":"396","author":"Mackenzie","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2024.103792_bib114","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/dom.13656","article-title":"Association between allopurinol and cardiovascular outcomes and all-cause mortality in diabetes: a retrospective, population-based cohort study","volume":"21","author":"Weisman","year":"2019","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.numecd.2024.103792_bib115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/jim-2018-000774","article-title":"Case-control study examining the association between allopurinol use and ischemic cerebrovascular disease","volume":"67","author":"Lai","year":"2019","journal-title":"J Invest Med"},{"key":"10.1016\/j.numecd.2024.103792_bib116","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/rheumatology\/kez576","article-title":"Comparative cardiovascular risk in users versus non-users of xanthine oxidase inhibitors and febuxostat versus allopurinol users","volume":"59","author":"Ju","year":"2020","journal-title":"Rheumatology"},{"issue":"22","key":"10.1016\/j.numecd.2024.103792_bib117","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/eurheartj\/ehz119","article-title":"Febuxostat for cerebral and CaRdiorenovascular events PrEvEntion StuDy","volume":"40","author":"Kojima","year":"2019","journal-title":"Eur Heart J"},{"issue":"26","key":"10.1016\/j.numecd.2024.103792_bib118","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","article-title":"Effects of allopurinol on the progression of chronic kidney disease","volume":"382","author":"Badve","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.numecd.2024.103792_bib119","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","article-title":"Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial","volume":"72","author":"Kimura","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"26","key":"10.1016\/j.numecd.2024.103792_bib120","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","article-title":"Serum urate lowering with allopurinol and kidney function in type 1 diabetes","volume":"382","author":"Doria","year":"2020","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.numecd.2024.103792_bib121","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","article-title":"Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study","volume":"51","author":"Hare","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.numecd.2024.103792_bib122","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.114.014536","article-title":"Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study","volume":"131","author":"Givertz","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2024.103792_bib123","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(10)60391-1","article-title":"High dose allopurinol prolongs exercise in chronic stable angina: a randomised placebo controlled trial","volume":"375","author":"Noman","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2024.103792_bib124","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/01.HYP.35.3.746","article-title":"Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension","volume":"35","author":"Butler","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2024.103792_bib125","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.CIR.0000046448.26751.58","article-title":"Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers","volume":"107","author":"Guthikonda","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.numecd.2024.103792_bib126","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.hjc.2017.01.004","article-title":"Clinical Study on efficacy of allopurinol in patients with acute coronary syndrome and its functional mechanism","volume":"58","author":"Huang","year":"2017","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.numecd.2024.103792_bib127","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(22)01657-9","article-title":"On behalf of the ALL-HEART Study Group. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Mackenzie","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2024.103792_bib128","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejim.2023.03.021","article-title":"Clinical implications of the biological ambivalence of uric acid","volume":"112","author":"Desideri","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.numecd.2024.103792_bib129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejim.2023.04.006","article-title":"Xanthine oxidase inhibition and cardiovascular protection: don't shoot in the dark","volume":"113","author":"Desideri","year":"2023","journal-title":"Eur J Intern Med"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324004265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324004265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T20:17:16Z","timestamp":1741810636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475324004265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":129,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0939475324004265"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2024.103792","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two still unanswered questions about uric acid and cardiovascular prevention: Is a specific uric acid cut-off needed? Is hypouricemic treatment able to reduce cardiovascular risk?","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2024.103792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}],"article-number":"103792"}}